Ocular streptococcal infections: A clinical and microbiological review.

Upeka Nanayakkara, Muhammad A Khan, Dilnoor K Hargun, Shobini Sivagnanam, Chameen Samarawickrama

Journal: Survey of ophthalmology 2023;68(4):678-696

PMID: 36764397

Abstract

Streptococcus is a diverse bacterial genus that is part of the ocular surface microbiome implicated in conjunctivitis, keratitis, endophthalmitis, dacryocystitis, and orbital cellulitis that can lead to decreased visual acuity and require surgical intervention. The pathophysiology of S. pneumoniae is well-established and the role of the polysaccharide capsule, pneumolysin, neuraminidases, and zinc metalloproteinases in ocular infections described. Additionally, key virulence factors of the viridans group streptococci such as cytolysins and proteases have been outlined, but there is a paucity of research on the remaining streptococcus species. These virulence factors tend to result in aggressive disease. Clinically, S. pneumoniae is implicated in 2.7-41.2% of bacterial conjunctivitis cases, more predominant in the pediatric population, and is implicated in 1.8-10.7% of bacterial keratitis isolates. Streptococcus bacteria are significantly implicated in acute postoperative, postintravitreal, and bleb-associated endophthalmitis, responsible for 10.3-37.5, 29.4, and 57.1% of cases, respectively. Group A and B streptococcus endogenous endophthalmitis is rare, but has a very poor prognosis. Inappropriate prescription of antibiotics in cases of nonbacterial aetiology has contributed to increasing resistance, and a clinical index is needed to more accurately monitor this. Furthermore, there is an increasing need for prospective, surveillance studies of antimicrobial resistance in ocular pathogens, as well as point-of-care testing using molecular techniques.

Crown Copyright © 2023. Published by Elsevier Inc. All rights reserved.

Address: University of New South Wales, Sydney, New South Wales, Australia.; Blacktown Hospital, Sydney, New South Wales, Australia; Australian Clinical Labs, Bella Vista, Sydney, New South Wales, Australia.; University of Sydney, New South Wales, Australia; Translational Ocular Research and Immunology Consortium (TORIC), Westmead Institute for Medical Research, Westmead, New South Wales, Australia. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.